Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)

NCT02865109 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Infantile-onset Spinal Muscular Atrophy

Interventions

DRUG: Nusinersen

Sponsor

Biogen